ArticleFrontiers in endocrinology2022

Retrospective analysis of leflunomide and low-dose methylprednisolone for the treatment of diabetic nephropathy combined with membranous nephropathy.

Shunlai Shang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.